Table 3 Fatty acid composition of the placebo and DHA-rich algae oil capsules.
Fatty acid composition expressed as % the total fatty acids | DHA-rich algae oil capsule | Placebo capsule |
|---|---|---|
14:0 | 5.90 | 0.07 |
16:0 | 17.0 | 10.7 |
Cis-9 16:1 | 0.10 | 0.10 |
18:0 | 0.65 | 3.38 |
Trans-9 18:1 | 0.18 | 0.00 |
Cis-9 18:1 | 6.59 | 25.9 |
Cis-11 18:1 | 0.20 | 1.34 |
Cis-9,trans-12 18:2 | 0.0 | 0.26 |
Trans-9,cis-12 18:2 | 0.0 | 0.21 |
20:0 | 0.12 | 0.40 |
20:1 n-9 | 0.00 | 0.22 |
22:0 | 0.14 | 0.36 |
24:0 | 0.24 | 0.15 |
n-6 fatty acids | ||
18:2 n-6 (LA) | 0.80 | 52.4 |
18:3 n-6 (ALA) | 0.31 | 0.03 |
20:3 n-6 | 0.46 | 0.0 |
20:4 n-6 (AA) | 0.48 | 0.0 |
22:4 n-6 | 0.13 | 0.0 |
22:5 n-6 (n-6 DPA) | 19.0 | 0.02 |
n-3 fatty acids | ||
18:3 n-3 | 0.0 | 4.49 |
18:4 n-3 | 0.36 | 0.01 |
20:4 n-3 | 0.96 | 0.0 |
20:5 n-3 (EPA) | 1.15 | 0.0 |
22:3 n-3 | 0.01 | 0.0 |
22:5 n-3 (n-3 DPA) | 0.59 | 0.0 |
22:6 n-3 (DHA) | 44.6 | 0.06 |
Ratio or sum | ||
∑n-3/∑n-6 | 2.25 | 0.09 |
DHA:n-6 DPA | 2.35 | 3.0 |
∑n-6 | 21.2 | 52.9 |
∑n-3 | 47.7 | 4.56 |
∑Saturated | 24.0 | 15.1 |
∑Trans fatty acids | 0.18 | 0.47 |
∑Cis fatty acids | 75.8 | 84.5 |
